Operation of a radiopharmacy for a clinical trial

Seminars in Nuclear Medicine

Volumn 40, Issue 5, 2010, Pages 347-356

  Norenberg, Jeffrey P ^a   Petry, Neil A ^b   Schwarz, Sally ^c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON 14; ENDOTOXIN; FLUORINE 18; IODINE 123; IODINE 131; MOLYBDENUM 99; NEW DRUG; PERTECHNETIC ACID TC 99M; RADIOPHARMACEUTICAL AGENT; STRONTIUM 89; TECHNETIUM 99M; TRITIUM; YTTRIUM 90;

BILLING AND CLAIMS; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COST CONTROL; DRUG ABSORPTION; DRUG CONTROL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG LABELING; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG METABOLISM; DRUG SAFETY; DRUG STORAGE; EMERGENCY CARE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HOSPITAL PHARMACY; HUMAN; INSTITUTIONAL REVIEW; INSTRUMENT STERILIZATION; MEDICAL AUDIT; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MEDICATION ERROR; MICROBIAL CONTAMINATION; PHARMACY; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; RADIOACTIVITY; REVIEW;

CLINICAL AUDIT; CLINICAL TRIALS AS TOPIC; GUIDELINE ADHERENCE; HUMANS; ORGANIZATIONAL POLICY; PHARMACEUTICAL SERVICES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RISK; STERILIZATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77955706722     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2010.06.002     Document Type: Review

References (14)

1. ICH Secretariat ICH Harmonised Tripartite Guideline for Good Clinical Practice (ICH GCP) 1996 ICH Geneva, Switzerland
2. Food and Drug Administration International conference on harmonization: good clinical practice consolidated guidelines Fed Regist 62 1997 25692 25709
3. The Joint Commission Manual, 2010 Edition, Medical Management Chapter, Standard MM.06.01.05, Joint Commission Resources 2010
4. American Society of Health-System Pharmacists ASHP guidelines on clinical drug research Am J Health Syst Pharm 55 1998 369 376
5. S.M. Mark, and R.J. Weber Advanced practice programs in hospital pharmacy-investigational drug services Hospital Pharmacy 43 2008 143 148
6. United States Pharmacopeia, 32nd Edition, General Chapter <797>, Pharmaceutical CompoundingSterile Preparations, May 1, 2009, pp 318-354
7. Federal Register, Vol 74, December 10, 2009, p 65409
8. Federal Register, Vol 74, December 10, 2009, p 65538
9. United States Pharmacopeia, 32nd Edition, General Chapter <823>, Radiopharmaceuticals for Positron Emission Tomography-Compounding, May 1, 2009, pp 365-369
10. Food and Drug Administration Institutional review board inspections IRB operations and clinical investigation information sheet www.fda.gov/oc/ohrt/ irbs/operations.html Accessed May 15, 2002
11. American Society of Health-System Pharmacists Investigational Drug Services, Resource Center www.ashp.org/IDS Accessed February 27, 2010
12. S. Siden, R.M. Tankanow, and H.R. Tamer Understanding and preparing for clinical drug trial audits Am J Health Syst Pharm 59 2002 2301 2306
13. M.S. McDonagh, S.A. Miller, and E. Naden Cost and savings if investigational drug services Am J Health Syst Pharm 57 2000 40 43
14. N. Shehab, and H. Tamer Dispensing investigational drugs: Regulatory issues and the role of the investigational drug service Am J Health Syst Pharm 61 2004 1882 1884